Top Markets
Coin of the day
Eurobio Scientific Société anonyme Eurobio Scientific Société anonyme

Eurobio Scientific Société anonyme

ALERS
Kedudukan dalam Saham #10853
Eurobio Scientific Société anonyme designs, develops, and commercializes... Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Harga Saham
$25.15
Modal Pasaran
$253.18M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-12.08%
Negara
FR
Perdagangan Eurobio Scientific Société anonyme (ALERS)

Kategori

Hasil untuk Eurobio Scientific Société anonyme (ALERS)
Hasil pada Dec 2025 TTM: $197.93M
Menurut laporan kewangan terkini daripada Eurobio Scientific Société anonyme, hasil semasa syarikat (TTM) ialah $197.93M. Pada tahun 2023, syarikat memperoleh hasil sebanyak $144.42M penurunan berbanding hasil pada tahun 2022 iaitu $163.70M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Eurobio Scientific Société anonyme dari 2007 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $197.93M 22.76%
2024 $161.23M 11.64%
2023 $144.42M -11.77%
2022 $163.70M -22.07%
2021 $210.04M -8.68%
2020 $230.00M 244.68%
2019 $66.73M 13.70%
2018 $58.69M 14.33%
2017 $51.33M 75.33%
2016 $29.28M -9.46%
2015 $32.34M -13.91%
2014 $37.56M -12.50%
2013 $42.93M 504.10%
2012 $7.11M 9.96%
2011 $6.46M -42.58%
2010 $11.25M 60.45%
2009 $7.01M 19.30%
2008 $5.88M -25.30%
2007 $7.87M 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
$45.13B 22,702.70%
US
$25.27B 12,666.97%
US
$36.37B 18,275.31%
IE
$20.62B 10,315.16%
US
$6.30B 3,084.67%
US